Skip to main content
Clinical Trials/EUCTR2013-001850-83-FR
EUCTR2013-001850-83-FR
Active, Not Recruiting
Phase 1

Adaptation to neonatal life after an anesthetic protocol using remifentanil for general anesthesia for caesarean section in a context of prematurity - REAGI Protocol (Remifentanil for General Anesthesia in the context of Immaturity) - REAGI

CHU- Hôpitaux de Rouen0 sites60 target enrollmentSeptember 24, 2015

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
pregnant woman older than 18 years with an indication for caesarean section under general anesthesia in a context of prematurity.
Sponsor
CHU- Hôpitaux de Rouen
Enrollment
60
Status
Active, Not Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 24, 2015
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CHU- Hôpitaux de Rouen

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria of the mother:
  • \- Patient over 18 years
  • \- Single pregnancy with an indication for cesarean section under general anesthesia context of prematurity (\<37SA)
  • \- Patient informed and written consent for participation in this research signed
  • \- Affiliation to social security
  • Inclusion criteria of the child:
  • Parents informed and written consent signed by the father and mother for the participation in this research by the child (unless a parent no longer has parental authority)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • Non\-inclusion criteria of the mother:
  • \- Vaginal Delivery
  • \- Mother pathology requiring the use of an opioid during induction
  • \- Severe Preeclampsia
  • \- More than 14 weeks between the information and the inclusion
  • \- Patient under guardianship
  • Non\-inclusion criteria of the child:
  • Fetal pathology diagnosed in the prenatal period involving the prognosis of the child

Outcomes

Primary Outcomes

Not specified

Similar Trials